Daniel Hart is a recurring editorial persona used by Supplement Brief for evidence-aware supplement explainers, buying-guide frameworks, and claims analysis. The role focuses on translating clinical research, supplement-label details, safety limitations, and commercial disclosure into practical reader decisions.
Daniel is not presented as a physician, pharmacist, dietitian, or medical reviewer. Medical claims are reviewed against cited sources and Supplement Brief editorial standards. Articles that receive review from a named clinician or credentialed specialist will state that separately in the byline.
Editorial Focus
- Supplement claims and evidence strength
- GLP-1 companion nutrition and metabolic-support products
- Dose, form, testing, safety caveats, and medication-context review
- Affiliate disclosure and non-hype commercial framing
Disclosure
Daniel Hart is a stable editorial contributor identity for Supplement Brief, not a public medical credential. This helps keep article voice consistent while avoiding fake medical authority. Supplement Brief may earn a commission from some links, but affiliate relationships do not determine editorial conclusions.
